Gilteritinib fumarate
Jump to navigation
Jump to search
| Gilteritinib fumarate | |
|---|---|
| Term | Gilteritinib fumarate |
| Short definition | Gilotrif (JEE-loh-trif) A drug used to treat certain types of non-small cell lung cancer that have spread to other parts of the body. It is used in patients whose cancer has not yet been treated and who have certain mutations (changes) in the cancer's EGFR gene, or whose cancer has gotten worse after treatment with platinum chemotherapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
gilteritinib fumarate - (pronounced) (GIL-teh-RIH-tih-nib FYOO-muh-rayt) A drug used to treat adults with acute myeloid leukemia that has come back or has not improved with other treatments and have a mutation (change) in the leukemia FLT3 gene. Gilteritinib fumarate blocks certain proteins that can prevent cancer cells from growing. It's a type of tyrosine kinase inhibitor. Also called Xospata
External links
- Medical encyclopedia article on Gilteritinib fumarate
- Wikipedia's article - Gilteritinib fumarate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski